Palvella Therapeutics, Inc. · NASDAQ:PVLA
Frazier Life Sciences Public Fund, L.P. reported a 6.00% stake in Palvella Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Frazier Life Sciences Public Fund, L.P. reported a 6.00% stake in Palvella Therapeutics, Inc., 706,360 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 6.00%
- Shares
- 706,360
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 14 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 6.00% | 706,360 |
| FHMLSP, L.P. | 6.00% | 706,360 |
| FHMLSP, L.L.C. | 6.00% | 706,360 |
| Frazier Life Sciences X, L.P. | 0% | 4,730 |
| FHMLS X, L.P. | 0% | 4,730 |
| FHMLS X, L.L.C. | 0% | 4,730 |
| Frazier Life Sciences XI, L.P. | 0.10% | 7,517 |
| FHMLS XI, L.P. | 0.10% | 7,517 |
| FHMLS XI, L.L.C. | 0.10% | 7,517 |
| Frazier Life Sciences XII, L.P. | 0% | 3,793 |
| FHMLS XII, L.P. | 0% | 3,793 |
| FHMLS XII, L.L.C. | 0% | 3,793 |
| James N. Topper | 0% | 4,730 |
| Patrick J. Heron | 0% | 4,730 |
Source
Related
- Palvella Therapeutics, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Palvella Therapeutics, Inc. shareholders
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2025
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · May 15, 2025
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Jan 8, 2025
- Form 4 · Goin Kathleen · Oct 23, 2026
- Form 4 · Jenkins George M · Oct 14, 2026
- Form 4 · Goin Kathleen · Sep 18, 2026
- Form 4 · Jenkins George M · Sep 15, 2026
- Form 4 · Kiritsy Christopher P · Sep 4, 2026